Adeniji E, Asante KP, Boahen O, et al, for the RTS,S Epidemiology PEI-MAL-005 Study Group. Estimating annual fluctuations in malaria transmission intensity and in the use of malaria control interventions in five sub-Saharan African countries. Am J Trop Med Hyg 2020 (published online Sep 21)
Ahouidi A, Ali M, Almagro-Garcia J, et al. An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples. Wellcome Open Research 2021 (published online Feb 24--awaiting peer review)
Al-Rumhi A, Al-Hashami Z, Al-Hamidhi S, et al. Influx of diverse, drug resistant and transmissible Plasmodium falciparum into a malaria-free setting in Qatar. BMC Infect Dis 2020 Jun 15;20:413
Bath D, Cook J, Govere J, et al. Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa. Lancet 2021 Feb 27–Mar 5;397(10276):816-27
Bria YP, Yeh CH, Bedingfield S. Significant symptoms and non-symptom-related dactors for malaria diagnosis in endemic regions of Indonesia. Int J Infect Dis 2020 (published online Nov 25)
Briggs J, Teyssier N, Nankabirwa JI, et al. Sex-based differences in clearance of chronic Plasmodium falciparum infection. eLife 2020 (published online Oct 27)
Bundi CK, Nalwoga A, Lubyayi L, et al. Iron deficiency is associated with reduced levels of Plasmodium falciparum-specific antibodies in African children. Clin Infect Dis 2020 (published online Jun 7)
Carrasco-Tenezaca M, Jawara M, Abdi MY, et al. The relationship between house height and mosquito house entry: an experimental study in rural Gambia. J R Soc Interface 2021 (published online May 26)
Chughlay MF, el Gaaloul M, Donini C, et al. Chemoprotective antimalarial activity of P218 against Plasmodium falciparum: a randomized, placebo-controlled volunteer infection study. Am J Trop Med Hyg 2021 (published online Feb 80)
Cohee LM, Opondo C, Clarke SE, et al. Preventive malaria treatment among school-aged children in sub-Saharan Africa: a systematic review and meta-analyses. Lancet Glob Health 2020 (published online Oct 23)
Commons RJ, Simpson JA, Watson J, et al. Estimating the proportion of Plasmodium vivax recurrences caused by relapse: a systematic review and meta-analysis. Am J Trop Med Hyg 2020 (published online Jun 8)
Corder RM, deLima AC, Khoury DS, et al. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: an observational and modeling study in Brazil. PLoS Negl Trop Dis 2020 (published online Jul 31)
Coulibaly D, GUindo B, Niangaly A, et al. A decline and age shift in malaria incidence in rural Mali following implementation of seasonal malaria chemoprevention and indoor residual spraying. J Am Trop Med Hyg 2021 Mar 3;104(3)
Dabirea ED, Hachizovu S, Conteh B, et al. Efficacy, safety and tolerability of pyronaridine-artesunate in asymptomatic malaria-infected individuals: a randomized controlled trial. Clin Infect Dis 2021 (published online May 13)
Datoo MS, Natama MH, Some A, et al. Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. Lancet 2021 (published online May 5)
Devine A, Battle K, Meagher N, et al. Global economic costs due to vivax malaria and the potential impact of its radical cure: a modelling study. PLOS Med 2021 (published online Jun 1)
Diallo MS, Toure A, Sow MS, et al. Understanding the long-term evolution and predictors of sequelae of Ebola virus disease survivors in Guinea: a 48-month prospective, longitudinal cohort study. Clin Infect Dis 2021 (published online Feb 23)
Druetz T, Stresman G, Ashton RA, et al. The immediate effects of a combined mass drug administration and indoor residual spraying campaign to accelerate progress towards malaria elimination in Grande-Anse, Haiti. J Infect Dis 2021 (published online May 16)
Fischer L, Gultekin N, Kaelin MB, et al. Rising temperature and its impact on receptivity to malaria transmission in Europe: a systematic review. Trav Med Infect Dis 2020 (published online Jul 3)
Foko LP, Arya A, Sharma A, et al. Epidemiology and clinical outcomes of severe Plasmodium vivax malaria in India. J Infect 2021 (published online Apr 5)
Galatas B, Saute F, Marti-Soler H, et al. A multiphase program for malaria elimination in southern Mozambique (the Magude project): a before-after study. PLoS Med 2020 (published online Aug 14)
Gebrekidan MG, Gebremedhin GB, Gebregiorgis YS, et al. Artemether-lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study. Antimicrob Resist Infect Control 2020 Nov 10;9:184
Gilmartin C, Nonvignon J, Cairns M, et al. Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis. Lancet Global Health 2021 Feb;9(2):E199-208
Global Fund. The impact of COVID-19 on HIV, TB and malaria services and systems for health: a snapshot from 502 health facilities across Africa and Asia. Geneva Switzerland: The Global Fund to Fight AIDS Tuberculosis and Malaria, Apr 2021
